These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10025944)

  • 1. Cardiomegaly in the juvenile visceral steatosis (JVS) mouse is reduced with acute elevation of heart short-chain acyl-carnitine level after L-carnitine injection.
    Kuwajima M; Horiuchi M; Harashima H; Lu K; Hayashi M; Sei M; Ozaki K; Kudo T; Kamido H; Ono A; Saheki T; Shima K
    FEBS Lett; 1999 Jan; 443(3):261-6. PubMed ID: 10025944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency.
    Kuwajima M; Lu K; Sei M; Ono A; Hayashi M; Ishiguro K; Ozaki K; Hotta K; Okita K; Murakami T; Miyagawa J; Narama I; Nikaido H; Hayakawa J; Nakajima H; Namba M; Hanafusa T; Matsuzawa Y; Shima K
    J Mol Cell Cardiol; 1998 Apr; 30(4):773-81. PubMed ID: 9602426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiency.
    Yoshimine K; Horiuchi M; Suzuki S; Kobayashi K; Abdul JM; Masuda M; Tomomura M; Ogawa Y; Itoh H; Nakao K; Osame M; Saheki T
    J Mol Cell Cardiol; 1997 Feb; 29(2):571-8. PubMed ID: 9140816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice.
    Yokogawa K; Higashi Y; Tamai I; Nomura M; Hashimoto N; Nikaido H; Hayakawa J; Miyamoto K; Tsuji A
    J Pharmacol Exp Ther; 1999 Apr; 289(1):224-30. PubMed ID: 10087008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine transport defect in fibroblasts of juvenile visceral steatosis (JVS) mouse.
    Kuwajima M; Lu K; Harashima H; Ono A; Sato I; Mizuno A; Murakami T; Nakajima H; Miyagawa J; Namba M; Hanafusa T; Hayakawa J; Matsuzawa Y; Shima K
    Biochem Biophys Res Commun; 1996 Jun; 223(2):283-7. PubMed ID: 8670273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in distinct species of 1,2-diacylglycerol in cardiac hypertrophy due to energy metabolic disorder.
    Saburi Y; Okumura K; Matsui H; Hayashi K; Kamiya H; Takahashi R; Matsubara K; Ito M
    Cardiovasc Res; 2003 Jan; 57(1):92-100. PubMed ID: 12504818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of carnitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency.
    Nakajima T; Horiuchi M; Yamanaka H; Kizaki Z; Inoue F; Kodo N; Kinugasa A; Saheki T; Sawada T
    Pediatr Res; 1997 Jul; 42(1):108-13. PubMed ID: 9212045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood.
    Tomomura M; Tomomura A; Musa DA; Horiuchi M; Takiguchi M; Mori M; Saheki T
    J Biochem; 1997 Jan; 121(1):172-7. PubMed ID: 9058209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catecholamine metabolism inhibitors and receptor blockades only partially suppress cardiac hypertrophy of juvenile visceral steatosis mice with systemic carnitine deficiency.
    Jalil A; Horiuchi M; Nomoto M; Kobayashi K; Saheki T
    Life Sci; 1999; 64(13):1137-44. PubMed ID: 10210276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate dehydrogenase kinase 4 mRNA is increased in the hypertrophied ventricles of carnitine-deficient juvenile visceral steatosis (JVS) mice.
    Horiuchi M; Kobayashi K; Masuda M; Terazono H; Saheki T
    Biofactors; 1999; 10(2-3):301-9. PubMed ID: 10609898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged effect of single carnitine administration on fasted carnitine-deficient JVS mice regarding their locomotor activity and energy expenditure.
    Li MX; Yoshida G; Horiuchi M; Kobayashi K; Saheki T
    Biochim Biophys Acta; 2006 Oct; 1761(10):1191-9. PubMed ID: 17027329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant changes in the hypertrophied heart due to energy metabolic disorder.
    Kamiya H; Okumura K; Ito M; Matsui H; Saburi Y; Hayashi K; Hayakawa T
    Basic Res Cardiol; 2001 Sep; 96(5):431-8. PubMed ID: 11605989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency.
    Horiuchi M; Yoshida H; Kobayashi K; Kuriwaki K; Yoshimine K; Tomomura M; Koizumi T; Nikaido H; Hayakawa J; Kuwajima M
    FEBS Lett; 1993 Jul; 326(1-3):267-71. PubMed ID: 8325377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slc22a5 haploinsufficiency does not aggravate the phenotype of the long-chain acyl-CoA dehydrogenase KO mouse.
    Ranea-Robles P; Yu C; van Vlies N; Vaz FM; Houten SM
    J Inherit Metab Dis; 2020 May; 43(3):486-495. PubMed ID: 31845336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The signaling pathway of cardiotrophin-1 is not activated in hypertrophied ventricles of carnitine-deficient juvenile visceral steatosis (JVS) mice.
    Yoshida G; Horiuchi M; Kobayashi K; Jalil MD; Iijima M; Hagihara S; Nagao N; Saheki T
    In Vivo; 2000; 14(3):401-5. PubMed ID: 10904873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressure overload-induced cardiomyopathy in heterozygous carrier mice of carnitine transporter gene mutation.
    Takahashi R; Asai T; Murakami H; Murakami R; Tsuzuki M; Numaguchi Y; Matsui H; Murohara T; Okumura K
    Hypertension; 2007 Sep; 50(3):497-502. PubMed ID: 17664396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency.
    Asai T; Okumura K; Takahashi R; Matsui H; Numaguchi Y; Murakami H; Murakami R; Murohara T
    Cardiovasc Res; 2006 Jun; 70(3):566-77. PubMed ID: 16546150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of the feeding response to fasting in carnitine-deficient juvenile visceral steatosis (JVS) mice: involvement of defective acyl-ghrelin secretion and enhanced corticotropin-releasing factor signaling in the hypothalamus.
    Sakoguchi T; Horiuchi M; Asakawa A; Ushikai M; Yoshida G; Fujimiya M; Kato I; Nakazato M; Takeuchi T; Saheki T; Inui A
    Biochim Biophys Acta; 2009 Nov; 1792(11):1087-93. PubMed ID: 19744557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of carnitine deprivation on carnitine homeostasis and energy metabolism in mice with systemic carnitine deficiency.
    Knapp AC; Todesco L; Torok M; Beier K; Krähenbühl S
    Ann Nutr Metab; 2008; 52(2):136-44. PubMed ID: 18417958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the up- and down-regulated genes in the heart of juvenile visceral steatosis mice.
    Suenaga M; Kuwajima M; Himeda T; Morokami K; Matsuura T; Ozaki K; Arakaki N; Shibata H; Higuti T
    Biol Pharm Bull; 2004 Apr; 27(4):496-503. PubMed ID: 15056854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.